关于医用大麻的在线信息可能会引起不切实际的期望并淡化潜在的副作用
Online information on medical cannabis may rise unrealistic expectations and downplay potential side effects
摘要：
关于大麻和大麻素化合物的潜在医疗用途的文献越来越多。尽管这些药物只被监管机构批准用于少数适应症，但人们对它们在各种条件下的可能益处和健康行业的巨大市场进行了炒作。由于在许多情况下，患者在网上搜索有关大麻产品的信息，我们分析了互联网上有关医用大麻的信息。通过对某搜索引擎返回的176个网页进行分析，发现其中一半以上是新闻网站。疼痛、癫痫和多发性硬化症是网页上最常提到的治疗领域，这些领域并不总是与监管机构批准的领域相匹配。信息也不完整，只有22%的网页提到了潜在的副作用。卫生门户网站提供的信息最为完整。平均而言，80%的网页对医用大麻的潜在好处持中立立场，商业网站更经常持积极立场（67%）。我们的结论是，可以在网上找到的信息可能会提高对治疗领域的不切实际的期望，而这些领域的科学证据往往仍然很薄弱。
英文摘要：
There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for few indications, there is a hype about their possible benefits in a variety of conditions and a large market in the wellness industry. As in many cases patients search for information on cannabis products online, we have analyzed the information on medical cannabis available on the Internet. Analyzing 176 webpages returned by a search engine, we found that more than half of them were news websites. Pain, epilepsy and multiple sclerosis were the most frequently therapeutic areas mentioned by the webpages, which did not always match those for which there is regulatory approval. Information was also incomplete, with only 22% of the webpages mentioning potential side effects. Health portal websites provided the most complete information. On average, 80% of webpages had a neutral stance on the potential benefits of medical cannabis, with commercial websites having more frequently a positive stance (67%). We conclude that the information that can be found online could raise unrealistic expectations regarding therapeutic areas for which science-based evidence is often still weak.
机构、总结、中文摘要均由AI分析而来，可能存在错误，请以论文正文为准。
